Values as of: 2025-03-11
COMMON STOCK | Farm Products |
Last Closing
USD 28.52Change
+0.32 (+1.13)%Market Cap
USD 0.23BVolume
0.06MAnalyst Target
USD 38.00Verdict
Verdict
Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates in two segments: Alico Citrus, and Land Management and Other Operations. The Alico Citrus segment engages in planting, owning, and cultivating or managing citrus groves to produce fruit for sale to fresh and processed citrus markets, as well as purchasing and reselling of fruit and value-added services, which includes contracting for the harvesting, marketing, and hauling of citrus. The Land Management and Other Operations that includes grazing and hunting leasing, management, and/or conservation of unimproved native pastureland, and activities related to rock mining royalties and other business; and owning or leasing of improved farmland. The company was incorporated in 1960 and is based in Fort Myers, Florida.
Company Website : https://www.alicoinc.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SFD | Smithfield Foods, Inc. Common .. |
+0.65 (+3.49%) |
USD 8.35B |
| CALM | Cal-Maine Foods Inc |
+0.26 (+0.30%) |
USD 4.43B |
| VITL | Vital Farms Inc |
-0.44 (-1.37%) |
USD 1.58B |
| CHSCO | CHS Inc CO Pref |
+0.01 (+0.04%) |
USD 0.58B |
| CHSCL | CHS Inc CL Pref |
-0.01 (-0.04%) |
USD 0.56B |
| CHSCM | CHS Inc CM Pref |
+0.09 (+0.36%) |
USD 0.51B |
| CHSCN | CHS Inc CN Pref |
+0.13 (+0.51%) |
USD 0.44B |
| LMNR | Limoneira Co |
-0.07 (-0.33%) |
USD 0.40B |
| CHSCP | CHS Inc CP Pref |
+0.06 (+0.21%) |
USD 0.34B |
| AFRI | Forafric Global PLC Ordinary S.. |
-0.11 (-1.27%) |
USD 0.24B |
N/A
| Market Performance vs. Industry/Classification (Farm Products) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 9.99% | 95% | A | 87% | B+ | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 9.99% | 95% | A | 87% | B+ | ||
| Trailing 12 Months | |||||||
| Capital Gain | 5.20% | 76% | C+ | 67% | D+ | ||
| Dividend Return | 0.74% | 13% | F | 15% | F | ||
| Total Return | 5.94% | 76% | C+ | 65% | D | ||
| Trailing 5 Years | |||||||
| Capital Gain | -3.32% | 36% | F | 40% | F | ||
| Dividend Return | 13.83% | 25% | F | 39% | F | ||
| Total Return | 10.51% | 36% | F | 40% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -0.33% | 68% | D+ | 38% | F | ||
| Dividend Return | 2.52% | 59% | D- | 42% | F | ||
| Total Return | 2.85% | 25% | F | 63% | D | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 19.83% | 68% | D+ | 78% | C+ | ||
| Risk Adjusted Return | 12.70% | 59% | D- | 44% | F | ||
| Market Capitalization | 0.23B | 50% | F | 50% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
